In the first week of November, BioAgilytix Labs, LLC, a portfolio company of Riverside Partners, purchased Cambridge Biomedical. Both Cambridge and BioAgilytix are contract research organizations (CROs) that develop novel therapeutic biologics and biosimilars, specializing in large molecule bioanalysis. The transaction expands BioAgilytix’s global footprint and adds further capacity by joining Cambridge Biomedical’s CLIA-certified, CAP-accredited, […]
August proved to be another busy month for eHealth transactions. According to our Deal Search Online database, there were 18 acquisitions in the eHealth sector in July 2019, and 17 in August. The most popular targets this month were cloud-based and data-analytics providers. There were eight digital health transactions with that focus, including Water Street […]
MedPlast Inc., a portfolio company of JLL Partners and Water Street Healthcare Partners, announced the largest deal in the Medical Device sector in May 2018. The company, which provides integrated custom plastic processing solutions for finished medical devices, acquired the advanced surgical and orthopedics lines (ASO) from Integer (NYSE: ITGR) for $600 million. The transaction includes 10 […]
Patheon N.V., formerly Patheon, Inc., has been acquired by Thermo Fisher Scientific for $7.2 billion. This deal marks the largest year-to-date in the contract development and manufacturing market.
Vention Medical and its two core businesses were split and sold by KRG Capital Partners.
The market for contract research organizations (CROs) is hot in 2016. Fourteen deals have been announced so far this year, compared with five in all of 2015, 11 in 2014 and eight in 2013. The latest deal was announced on August 22, as JLL Partners and Water Street Healthcare Partners exited their investment in BioClinica, […]
Private equity-backed Bioclinica Inc. expanded its clinical research offerings with the July 2016 acquisition of Compass Research, LLC, a Florida-based clinical research site network that has direct access to a number of specialized populations with neurodegenerative disorders and other diseases found in aging demographics. The acquisition solidifies Bioclinica’s position as a leading global research network, and […]
BioClinica, Inc., a global provider of clinical trial management services, extended its offerings with the acquisition of MediciGroup, Inc., a global patient recruitment and retention firm. The acquisition includes MediciGlobal, Ltd. and Access to Patients, LLC. Medici also provides a lost-to-follow-up patient locate service that finds missing patients globally. BioClinica was taken private for $123 […]